Live Quote · NASDAQAKTSHealthcare· Biotechnology

Aktis Oncology, Inc.

$16.15▼ 1.52%($-0.25)
MKT CAP $868.01MNEXT EARNINGS Mar 29, 2027
50%
Bullish
TickerSpark Score
58/100
▌ Mixed
65
Valuation
40
Profitability
80
Growth
76
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AKTS research report →

Analyst Price Target
$37.40+131.6% vs. today

Range $35 – $40

Analyst RatingBuy
6 Buy3 Hold0 Sell

Price Chart

-26.79% · this period
$32.23$23.41$14.59Jan 09Jun 17Nov 19
52-Week Range11% of range
Low
$13.96
Current
$16.15
High
$34.19